Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05886868 |
| Title | Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Shanghai Best-Link Bioscience, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cancer Care Foundation Limited | ACTIVE_NOT_RECRUITING | Sydney | New South Wales | Australia | Details | |
| Scientia Clinical Research | RECRUITING | Sydney | New South Wales | Australia | Details | |
| Sunshine Coast University Private Hospital | ACTIVE_NOT_RECRUITING | Birtinya | Queensland | Australia | Details | |
| Cancer Hospital Chinese Academy of Medical Sciences | NOT_YET_RECRUITING | Beijing | Beijing | China | Details |